Endocrinology, Vol 116, 1603-1609, Copyright © 1985 by Endocrine Society

ARTICLES

Phorbol esters stimulate growth and inhibit differentiation in cultured thyroid cells

LK Bachrach, MC Eggo, WW Mak and GN Burrow

The potent tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) has biological effects on cell growth and differentiation similar to the effects of epidermal growth factor (EGF) on a variety of cells. Since EGF has been shown recently to stimulate thyroid cell proliferation and inhibit iodine metabolism, we examined the effects of phorbol esters on primary ovine thyroid cultures. TPA stimulated cell growth in a manner similar to EGF. The growth effects of EGF and TPA in combination were not additive. In contrast, TPA (1.6 X 10(-7) M) was a more potent inhibitor of iodine uptake and incorporation than EGF (10(- 9) M) at their maximally effective concentrations. The inhibitory effects of TPA were also more rapid and less reversible than those of EGF. TPA and EGF in combination inhibited iodine metabolism more than either agent alone at its maximally effective concentration. Both TPA and EGF reduced the accumulation of cAMP in TSH-stimulated cells, but (Bu)2cAMP and stimulators of adenylate cyclase failed to overcome TPA's inhibition of iodine metabolism. TPA interacted with EGF by reducing the affinity of membrane receptors for [125I]iodo-EGF. Although the alteration in EGF-receptor interaction induced by TPA may play a role in mediating TPA's biological effects, the additive effects of TPA and EGF on iodine metabolism suggest that TPA does not act solely through the EGF receptor-effector system. Agents other than TSH, including phorbol esters and EGF, are potent modulators of thyroid growth and differentiated function. Despite several similarities in biological activity, TPA and EGF do not modulate differentiated function in an identical manner. Both factors act at least partially through a non- cAMP-dependent pathway, providing indirect evidence of another second messenger(s) in the control of thyroid function.

This article has been cited by other articles:

				M. Eszlinger, K. Krohn, A. Kukulska, B. Jarzab, and R. Paschke Perspectives and Limitations of Microarray-Based Gene Expression Profiling of Thyroid Tumors Endocr. Rev., May 1, 2007; 28(3): 322 - 338. [Abstract] [Full Text] [PDF]

				M. Eszlinger, K. Krohn, K. Berger, J. Lauter, S. Kropf, M. Beck, D. Fuhrer, and R. Paschke Gene Expression Analysis Reveals Evidence for Increased Expression of Cell Cycle-Associated Genes and Gq-Protein-Protein Kinase C Signaling in Cold Thyroid Nodules J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1163 - 1170. [Abstract] [Full Text] [PDF]

				M. D. Ringel, M. Saji, W. F. Schwindinger, D. Segev, M. A. Zeiger, and M. A. Levine Absence of Activating Mutations of the Genes Encoding the {alpha}-Subunits of G11 and Gq in Thyroid Neoplasia J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 554 - 559. [Abstract] [Full Text]

				M. Broecker, G. W. Mayr, and M. Derwahl Suppression of Thyrotropin Receptor-G Protein-Phospholipase C Coupling by Activation of Protein Kinase C in Thyroid Carcinoma Cells Endocrinology, September 1, 1997; 138(9): 3787 - 3796. [Abstract] [Full Text] [PDF]

				C. Ledent, J.-F. Denef, S. Cottecchia, R. Lefkowitz, J. Dumont, G. Vassart, and M. Parmentier Costimulation of Adenylyl Cyclase and Phospholipase C by a Mutant {alpha}1B-Adrenergic Receptor Transgene Promotes Malignant Transformation of Thyroid Follicular Cells Endocrinology, January 1, 1997; 138(1): 369 - 378. [Abstract] [Full Text] [PDF]

				M. Zannini, A. Acebron, M. De Felice, M. I. Arnone, J. Martin-Pérez, P. Santisteban, and R. Di Lauro Mapping and Functional Role of Phosphorylation Sites in the Thyroid Transcription Factor-1 (TTF-1) J. Biol. Chem., January 26, 1996; 271(4): 2249 - 2254. [Abstract] [Full Text] [PDF]